NCT02763527

Brief Summary

Background: Smokers attended to outpatient clinics present an excellent 'teachable moment' for smoking cessation interventions. This protocol paper describes the rationale and methods of a large randomized controlled trial which aims to evaluate the effectiveness of negotiating self-determination to reduce cigarette consumption among smokers attending outpatient clinics Methods: A randomized controlled trial will be conducted in 10 out-patient clinics in Hong Kong. Subjects in the intervention group will receive a brief intervention on smoking reduction plus a smoking reduction leaflet. Additionally, subjects will be asked to think about a smoking reduction schedule for themselves after the negotiation with the counsellor. Subjects in the control group will receive a brief advice on quitting plus a leaflet on smoking cessation. Four consecutive (1, 3, 6 and 12 months) follow-ups will be conducted. The primary outcome measure is biochemically validated abstinence at 6 months. Secondary outcomes are: (i) biochemically validated abstinence at 12 months, (ii) self-reported 7-day point prevalence of abstinence at 6 and 12 months, (iii) self-reported reduction of ≥ 50% in cigarette consumption at 6 and 12 months, and (iv) self-efficacy against tobacco at 6 and 12 months.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,566

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 5, 2016

Completed
5.1 years until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

November 4, 2020

Status Verified

October 1, 2020

Enrollment Period

1.5 years

First QC Date

April 26, 2016

Last Update Submit

November 2, 2020

Conditions

Keywords

smoking cessation

Outcome Measures

Primary Outcomes (1)

  • biochemically validated abstinence using exhaled CO test

    6 months

Secondary Outcomes (9)

  • biochemically validated abstinence using exhaled CO test

    12 months

  • self-reported 7-day point prevalence of abstinence

    6 months

  • self-reported 7-day point prevalence of abstinence

    12 months

  • self-reported reduction of ≥ 50% in cigarette consumption

    6 months

  • self-reported reduction of ≥ 50% in cigarette consumption

    12 months

  • +4 more secondary outcomes

Study Arms (2)

Smoking reduction

EXPERIMENTAL

Subjects will receive a brief intervention on smoking reduction with a warning message plus a smoking reduction leaflet. They will be asked to think about a tailored smoking reduction schedule for themselves after the negotiation with the trained counsellor. The trained counsellor will negotiate a schedule with subjects to reduce their smoking over an acceptable level. For the subsequent telephone follow up in the intervention group, information on reduction and cessation will be collected, followed by a "booster" intervention, which will repeat the health warning to positively encourage them to reinforce their efforts and the next reduction target. Four consecutive (1, 3, 6 and 12 months) follow-ups will be conducted over the telephone by trained interviewers.

Behavioral: Smoking reduction

Smoking Cessation

PLACEBO COMPARATOR

Subjects in the QI group will always be advised to quit immediately rather than to quit progressively. Subjects will receive a brief advice on quitting with a warning message similar to subjects in the QP group. In addition, subjects will receive a self-help quitting pamphlet published by the Hong Kong Council on Smoking and Health (COSH). Unlike the QP group, subjects in the QI group will not receive smoking reduction intervention and leaflet, and "booster" intervention during telephone follow-ups. However, they will undergo a similar schedule of telephone follow-up as those in the QP group.

Behavioral: Smoking Cessation

Interventions

A brief intervention on smoking reduction plus a smoking reduction leaflet

Smoking reduction

A brief advice on quitting plus a leaflet on smoking cessation

Smoking Cessation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • smokers
  • who are Chinese
  • aged 18 years or above
  • who smoke at least two cigarettes per day
  • with moderate to severe nicotine dependence, and
  • have no intention to quit smoking ≤7 days, but are interested in reducing the number of cigarettes smoked per day .

You may not qualify if:

  • smokers
  • with unstable medical conditions as advised by the doctor in charge,
  • with poor cognitive state or mental illness,
  • who participate in other smoking cessation programmes or services,
  • with mild nicotine dependence, or
  • who claim that they can quit ≤7 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

SmokingSmoking Cessation

Condition Hierarchy (Ancestors)

BehaviorHealth Behavior

Study Officials

  • William, Ho Cheung LI, PhD

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

William, Ho Cheung LI, PhD

CONTACT

Ka Yan, HO Ho, MPhil

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2016

First Posted

May 5, 2016

Study Start

June 1, 2021

Primary Completion

December 1, 2022

Study Completion

December 1, 2023

Last Updated

November 4, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share